HF
OKUR

HRT Financial’s OnKure Therapeutics OKUR Stock Holding History

HRT Financial’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$153K Buy
+37,055
New +$114K ﹤0.01% 3261
2024
Q1 		– Sell
-8,735
Closed -$139K – 3236
2023
Q4 		$139K Buy
+8,735
New +$544K ﹤0.01% 1850

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HRT Financial's OKUR Position: Q1 2026 in Review

HRT Financial opened a new position in OnKure Therapeutics (OKUR) in Q1 2026: 37,055 shares worth $153K. The stake represents ﹤0.01% of the portfolio and ranks #3261 among its holdings. This is a return to the name: HRT Financial previously reported a position in OKUR as recently as Q4 2023.

HRT Financial first reported a position in OKUR in Q4 2023 and has held it in 2 quarters since. 51 funds tracked by Wall St. Rank hold OKUR as of Q1 2026.

  • HRT Financial held 37,055 shares of OnKure Therapeutics worth $153K as of Q1 2026.
  • OnKure Therapeutics was a new HRT Financial position in Q1 2026.
  • OnKure Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3261 holding.
  • HRT Financial first reported a position in OnKure Therapeutics in Q4 2023 and has held it in 2 quarters since.
  • 51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.